SOURCE: InforSense Ltd.

June 04, 2007 10:18 ET

InforSense Expands to Meet Customer Demand for Embedded Enterprise Analytics

Expands Into New Markets; Adds to Executive Team and Advisory Board; Establishes New Headquarters in London and USA

LONDON and CAMBRIDGE, MA--(Marketwire - June 4, 2007) - InforSense Ltd., the leading provider of embedded enterprise analytics, today announced that the company continues to expand to meet the growing demand for its best of breed solution. Embedded analytics is a key enabler for process-driven business intelligence.

"The BI market is forecast to show a five-year compound annual growth rate (CAGR) of 8.6%, reaching nearly $6.8 billion in 2011. As companies are standardizing around platforms and making BI more strategic and pervasive, and also increasingly embedding BI functionality into the workflow and business processes, the case for BI as a mission-critical necessity increases," noted Gartner, Inc. in its report "Forecast: Business Intelligence Platforms, Worldwide, 2006-2011," by Dan Sommer, Colleen Graham et al, October 2006.

Recently, Inforsense has:

--  Broadened its customer base into new markets beyond life science
    adding customers in financial services, telecommunications, manufacturing
    and health care.
--  Opened new international and US headquarters in London and in
    Cambridge, Massachusetts.
--  Added world renowned scientists in the field of life science, to their
    scientific advisory board.
--  Appointed Tobias Rother as Vice President of Business Operations,
    Continental Europe and Dave Menninger as Vice President of Marketing.
    

"Inforsense is acknowledged as a leader of informatics software platforms in the life sciences market. Our analytical technology has been successfully embedded into various business processes in drug discovery research and development at the world's top pharmaceutical companies and research institutes . This past year we have leveraged that success and expanded our business into new markets including healthcare, financial services and telecommunications," said CEO and Founder, Yike Guo. "As a result of increased customer demand, we have moved our headquarters to larger facilities and have added to the executive team to accommodate our growth."

Inforsense added twenty new customers across life sciences, healthcare, and financial services. Inforsense's customer base now includes 10 of the top 15 pharmaceutical companies, 2 of the top 5 consumer goods firms, several multibillion dollar financial services firms, several health care organizations and one of the world's largest telecommunications infrastructure providers.

Professor Jeremy Nicholson joins Inforsense's Scientific Advisory Board. Professor Nicholson heads the department of Biomolecular Medicine at Imperial College where he leads one of the world's largest research groups in metabolic science. He obtained his doctorate from the University of London and subsequently became a post-doctoral fellow and Professor of Biological Chemistry at Birkbeck College, London. He was awarded the Royal Society of Chemistry Gold and Silver Medals for Analytical Science, the Royal Society of Chemistry Silver medal for Chemical Biology, the Pfizer Global Research Prize for Chemistry and has published extensively in his field.

Tobias Rother brings 20 years of operating experience to Inforsense. He joins the company as Vice President of Business Operations from Software AG, where he served as Vice President of Business Process Management. Tobias is responsible for building Inforsense's business operations throughout continental Europe.

David Menninger joins Inforsense as Vice President Global Marketing and Product Management from Applix where he was Vice President of Worldwide Product Management and Marketing. Dave has over 25 years of experience and previously served as Vice President of Product Management for Oracle's Data Mining Technologies and Vice President of Product Marketing for Oracle's OLAP Division.

Inforsense has moved its international and US headquarters to new locations to accommodate growth. In order to keep up with the rising demand for its products and services, the company has increased headcount to over 100 employees during the past year, requiring a significant expansion of office space. The new addresses are

InforSense Limited                             InforSense LLC
Colet Court,                                   155 Second Street,
100 Hammersmith Road,                          Cambridge, MA 02141
London, W6 7JP                                 USA
United Kingdom                                 Tel.: +1 617 547 2500
Tel.: +44 (0) 20 8237 8440

About InforSense

InforSense Ltd., the leading provider of embedded enterprise analytics, enables organizations to orchestrate and optimize their business-critical decision-making processes. Leading pharmaceutical and biotechnology, consumer goods, healthcare, financial services companies, and research institutes are using the company's flagship product, InforSense, to enhance productivity by embedding analytics within their business processes. The company is privately held, with European headquarters in London, UK and North American headquarters in Cambridge, Massachusetts.

For more information visit www.inforsense.com

InforSense, TextSense and the InforSense logo are registered trademarks of InforSense Limited. All rights reserved. All other trademarks mentioned in this document are the property of their respective owners.

Contact Information

  • Contact:
    Lisa Allocca
    Red Javelin Communications, Inc.
    978-470-2227
    Email Contact